Stepan (SCL) Q3 2026 earnings review
Stepan's chemical sales volume rises, but working capital drains cash
Stepan, a maker of cleaning chemicals and insulation foams, grew underlying sales volume even after second-quarter customer stockpiling ended. Revenue rose 17% on higher chemical pass-through prices, while profit per share excluding one-offs nearly doubled to $0.94 as Chief Executive Luis E. Rojo cut 100 salaried jobs. However, rising customer bills and inventories absorbed cash, leaving $8 million of free cash flow.
| Sales volume from businesses owned a year ago | +7% +6% last quarter |
|---|---|
| Revenue | $692.2M +17.3% from a year ago |
| EBITDA, excluding one-offs | $66.3M +18.0% from a year ago |
| Full-year outlook | Unchanged EBITDA growth and positive free cash flow |
⚖️ Verdict: 🟢 Bullish
The story got better because customer demand held up on its own once middle-market and spray foam gains replaced last quarter's temporary pre-buying. One caution: net debt crept up to $536 million because higher prices tied up $102 million in working capital this year, forcing an October land sale to fund debt reduction.
The question now is whether Stepan can turn its paper profit recovery into cash before year-end. Either fourth-quarter working capital unwinds as seasonal construction slows, or elevated raw material prices keep cash trapped on the balance sheet. Fourth-quarter free cash flow, which needs to reach $21 million by our math to meet the full-year plan, will settle it.
🐂 Bull Case
Underlying Volume Accelerated Despite the Pre-Buy Reversal
Stepan makes surfactants, the cleaning agents in soap and agricultural sprays, and polymers used in building insulation. Customers bought extra stock in the second quarter to get ahead of supply chain disruptions, which threatened to leave a hole in third-quarter demand. Instead, sales volume from businesses owned a year ago rose 7%, faster than last quarter's 6% pace, while total global volume grew 3% after accounting for last year's Philippines plant sale.
- Surfactant underlying volume: up 8% from a year ago, with double-digit gains in consumer products, oilfield, and smaller middle-market (Tier 2 and 3) accounts
- Polymers volume: up 3% overall, led by double-digit growth in North American rigid insulation, spray foam, and phthalic anhydride
- Specialty Products volume: up 20%, driven by medium-chain triglycerides used in food and nutrition
Chief executive Luis E. Rojo said "The Surfactant volume growth was broad-based and across most end markets" except agricultural crop chemicals. Because growth accelerated even as second-quarter customer stockpiling unwound, the chemical maker's push into smaller accounts and spray foam is winning real business rather than riding an inventory bounce.
What to watch: fourth-quarter underlying volume growth and any dollar revenue disclosure for spray foam on the conference call. Sustaining mid-single-digit volume growth in the seasonally slowest quarter would confirm that new customer wins are outpacing weak construction demand.
Cost Cuts and Pricing Lifted Gross Margin
Project Catalyst is Stepan's two-year plan to close older plants and cut overhead. Rojo said the group "executed the organizational redesign phase of Project Catalyst during the quarter in line with expectations", eliminating about 100 salaried jobs, or 7% of its global salaried staff, for a $5.6 million pre-tax restructuring charge.
Those savings, combined with a 13% jump in selling prices and product mix, lifted gross margin by 0.6 percentage points from a year ago to 12.7%. The cost of making products fell from 88.0% of revenue to 87.3% by our math. Earnings before interest, taxes, depreciation, and amortisation (EBITDA) excluding one-offs reached $66.3 million, up 18% from last year and well clear of the $56.2 million prior-year base.
What to watch: management's update on the quarterly cost-savings rate on the conference call. Moving from the $18–20 million quarterly rate reported last quarter toward the $22 million year-end target would show the salaried job cuts are flowing into fourth-quarter profit.
🐻 Bear Case
Working Capital Drained Cash and Raised Debt
Rojo said Stepan expects to "continue to de-leverage the balance sheet in 2026" through its productivity plans and cash interventions. In reality, net debt (total debt minus cash) moved the wrong way again, rising $2.3 million from June to $536.0 million, and is now up $42.0 million since the start of the year.
- Free cash flow (operating cash flow minus capital spending): $8.2 million in the quarter, down 80% from $40.2 million a year ago
- Nine-month free cash flow: negative $20.8 million by our math, after negative $29.0 million in the first half
- Major working capital (receivables plus inventory minus payables): $526.9 million, up $31.8 million in the quarter and $101.8 million year-to-date by our math
Higher raw material costs and 13% higher selling prices inflated customer bills and inventory values, locking cash inside the balance sheet. The Illinois company did close the sale of land near its Millsdale plant in October for $28.5 million—$1.5 million below its earlier $30 million estimate—and will use the cash to pay down debt, but asset sales are doing the work that operating cash flow has not.
What to watch: fourth-quarter accounts receivable and inventory balances. Stepan needs at least $20.8 million of fourth-quarter free cash flow by our math to hit its full-year goal, which requires collecting customer bills as seasonal construction demand slows.
Easy Comparisons and Maintenance Masked Weak Segments
Rojo noted that "Quarterly earnings were up significantly, driven by improved results in all three segments". However, consolidated EBITDA excluding one-offs fell 10.9% from the second quarter's $74.4 million as pre-buying faded, and the 18% growth from a year ago rested heavily on an easy comparison in Surfactants.
Surfactant EBITDA excluding one-offs rose $10.2 million, or 27%, to $48.2 million. A year ago, that same quarter absorbed an $8.6 million pre-tax drag from starting up the Pasadena, Texas plant; stripping that one-off drag from the base leaves underlying Surfactant growth at 3.4% by our math. Meanwhile, Polymers revenue jumped 24% on raw material pass-throughs, but its EBITDA excluding one-offs rose only 4% to $23.3 million because of weak demand in Europe and Asia and "regulatory-mandated maintenance turnaround costs, that occur every 5 years, at the Company's Germany site".
What to watch: fourth-quarter Polymers EBITDA excluding one-offs. Once the German plant maintenance ends, Polymers profit growth should move closer to its revenue growth unless European construction demand worsens.
Risks this quarter didn't answer
Four standing risks from prior quarters either worsened slightly in the tables or received no new detail in the earnings release.
- Fixed-cost inflation vs cost cuts: corporate expenses excluding one-offs rose 6% from a year ago to $17.5 million on "higher incentive-based compensation expenses", and the release gives no figure for cost savings net of inflation.
- Environmental liabilities: Stepan booked a $3.1 million pre-tax ($2.4 million after-tax) charge for a "reserve adjustment related to the Company's Maywood, NJ site", up from $0.3 million a year ago.
- Short-term debt maturities: current debt fell from $403.3 million in June to $292.4 million by our math, but still sits nearly three times higher than the $98.1 million cash balance ahead of June 2027 credit facility maturities.
- Detergent reformulation: consumer product surfactant volumes grew double digits overall, leaving unquantified whether North American customers are still reformulating toward weaker detergents.
👓 Other Themes
Raw Material Pass-Throughs Drove Most Revenue Growth
Stepan's 17% revenue increase to $692.2 million came mostly from charging more to cover rising chemical input costs rather than selling more tonnage. Selling prices and product mix added 13 percentage points to sales growth—including a 22% price jump in Polymers and 10% in Surfactants—due to the "pass-through of higher raw material costs and pricing actions", while currency translation added 1 percentage point.
💲 Other KPIs
Spending on plants and equipment fell 28.7% from $29.6 million a year ago and 9.8% from $23.4 million in the second quarter. At 3.0% of revenue by our math, down from 5.0% a year ago, the lighter capital bill after finishing the Pasadena plant is the main reason third-quarter free cash flow turned positive.
Net interest costs fell 6.9% from $6.8 million a year ago, though they rose from $5.7 million in the second quarter. Through nine months, net interest expense is $17.0 million against a prior full-year forecast of $24–26 million, leaving room for fourth-quarter debt paydown from the October land sale.
🔮 Guidance
Unchanged. The chemical maker still plans to grow full-year EBITDA excluding one-offs above last year's $198.9 million. With $190.3 million already booked in the first nine months (up 15% from a year ago), the full-year outlook requires only $8.6 million in the fourth quarter by our math—a 74.6% drop from last year's $33.8 million fourth quarter, making the floor easy to clear.
Unchanged. Management still expects positive free cash flow for the full year. Because the first nine months sit at negative $20.8 million by our math (excluding the $28.5 million October land sale, which counts as an asset sale rather than operating cash flow), Stepan must generate at least $20.8 million in the fourth quarter, compared with $25.4 million in the fourth quarter of 2025.
❓ Key Questions
How much of the cost savings beat fixed-cost inflation?
Project Catalyst is cutting 100 salaried jobs, but corporate expenses excluding one-offs still rose 6% on incentive pay and inflation is running above 3% on a $750 million fixed cost base. Investors need the net savings reaching the bottom line.
Where do Pasadena utilisation and Catalyst quarterly savings stand?
Last quarter management reported $18–20 million in quarterly Catalyst savings and 75–80% utilisation at the new Pasadena plant. Neither figure is in the release; the call must show whether both stayed on track toward year-end targets.
Will fourth-quarter working capital release enough cash?
Receivables and inventory have tied up $101.8 million of cash this year as chemical prices rose 13%. Management needs to explain how much working capital will unwind in the fourth quarter to clear the $20.8 million free-cash-flow hurdle.
What is the refinancing plan for the 2027 debt?
Even after shifting some borrowings to long-term, Stepan carries $292.4 million of short-term debt by our math against $98.1 million of cash and $28.5 million from the October land sale, with its main credit facility maturing in June 2027.